Our stem cells are donated by mothers from the umbilical cord, placental tissues of a live healthy birth. These cells contains an abundance of growth factors, proteins, and regenerative cells (including stem cells). The cord blood is processed in such a way that all blood components associated with rejection are removed. When these growth factors, proteins, regenerative cells, and stem cells are injected into a damaged joint, they go to work immediately.
IL-1ra (Interleukin-1 receptor antagonist) immediately begins reducing the damaging inflammatory components (Tumor necrosis factor-alpha, Interferon-gamma, etc.). At the same time, the protein Vascular Endothelial Growth Factor (VEGF) stimulates blood supply for the damaged tissue, Fibroblast Growth Factor-2 (FGF-2) stimulates the damaged cells to grow and reproduce themselves, Transforming Growth Factor-beta (TGF-beta) stimulates cartilage to grow, and Stem Cell Factor (SCF) stimulates your native inactive stem cells to become activated and assist in the repair of the damaged tissue. This represents a small example of the thousands of growth factors, proteins, and regenerative cells involved in the reparative process that takes place when these cells are injected into a damaged joint.
This type of regenerative medicine utilizes a natural approach to optimize the environment within a damaged joint, and then stimulates your own tissue to repair itself.
Neuropathy is a condition in which the peripheral nerves (the nerves in your body, aside from your spinal cord and brain) are damaged and/or not working correctly. Neuropathic pain is characterized by pain, tingling and numbness in the feet and lower legs, balance problems and a variety of uncomfortable feelings. It can be quite debilitating, and affects more than 10% of the population. Diabetes is the leading cause of peripheral neuropathy.
RMI has developed a safe and effective treatment for patients who suffer from any form of acute and chronic pain, including peripheral neuropathy. Our unique treatment protocol- Cellular Signaling Therapy™ (CST) uses advanced medical electric technology, (cellular signaling therapy) in conjunction with stem cells. This method offers shortened treatment times and faster results.
Epidermal Nerve Fiber Density (ENFD) biopsies which have been found to have 88.4% sensitivity in detection of peripheral neuropathy compared to 54.6% for a clinical exam alone. ENFD is widely considered to be the “Gold Standard” in the detection of peripheral neuropathy.
Regenerative medicine physicians are changing the paradigm of medicine. The newest advancements in Stem Cell therapy uses healthy donated umbilical cord & placental tissue stem cells to treat a joint conditions, auto-immune diseases, and anti-aging procedures.